These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33351705)

  • 1. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
    Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E
    J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
    Paredes Aller S; Quittner AL; Salathe MA; Schmid A
    Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
    Guan WJ; Xu JF; Luo H; Xu XX; Song YL; Ma WL; Liang ZA; Liu XD; Zhang GJ; Zhang XJ; Li RK; Zhu SY; Zhang YJ; Cai XJ; Wei LP; Tian DB; Zhao H; Chen PY; Qu JM; Zhong NS;
    Chest; 2023 Jan; 163(1):64-76. PubMed ID: 35863486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Sangiovanni S; Morales EI; Fernández-Trujillo L
    Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiectasis and inhaled tobramycin: A literature review.
    Elborn JS; Blasi F; Haworth CS; Ballmann M; Tiddens HAWM; Murris-Espin M; Chalmers JD; Cantin AM
    Respir Med; 2022 Feb; 192():106728. PubMed ID: 34998112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).
    Loebinger MR; Polverino E; Blasi F; Elborn SJ; Chalmers JD; Tiddens HA; Goossens H; Tunney M; Zhou W; Angyalosi G; Hill AT; Haworth CS;
    Pulm Pharmacol Ther; 2019 Oct; 58():101834. PubMed ID: 31433997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
    Scheinberg P; Shore E
    Chest; 2005 Apr; 127(4):1420-6. PubMed ID: 15821224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.
    Sommerwerck U; Virella-Lowell I; Angyalosi G; Viegas A; Cao W; Debonnett L
    Curr Med Res Opin; 2016 Nov; 32(11):1789-1795. PubMed ID: 27435882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of
    Akkerman-Nijland AM; Yousofi M; Rottier BL; Van der Vaart H; Burgerhof JGM; Frijlink HW; Touw DJ; Koppelman GH; Akkerman OW
    Ther Adv Respir Dis; 2020; 14():1753466620905279. PubMed ID: 32046620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case reports of the treatment with tobramycin solution for inhalation in severe bronchiectasis patients continuous infection of Pseudomonas aeruginosa].
    Nakamura S; Yanagihara K; Morinaga Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2005 Jan; 43(1):41-7. PubMed ID: 15704452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
    Barker AF; Couch L; Fiel SB; Gotfried MH; Ilowite J; Meyer KC; O'Donnell A; Sahn SA; Smith LJ; Stewart JO; Abuan T; Tully H; Van Dalfsen J; Wells CD; Quan J
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):481-5. PubMed ID: 10934074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients.
    Wang S; Zhang A; Yao X
    Intern Med J; 2021 Sep; 51(9):1505-1512. PubMed ID: 33469994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of
    Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
    Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study.
    Mainz JG; Schädlich K; Schien C; Michl R; Schelhorn-Neise P; Koitschev A; Koitschev C; Keller PM; Riethmüller J; Wiedemann B; Beck JF
    Drug Des Devel Ther; 2014; 8():209-17. PubMed ID: 24596456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.